MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

John Robinson
  • Fremont, CA
  • United States
Share on Facebook Share on Facebook Share

John Robinson's Contacts

  • amelia
  • Lisa  A.

Gifts Received

Gift

John Robinson has not received any gifts yet

Give a Gift

 

John Robinson's Page

Latest Activity

John Robinson posted events
Feb 14
John Robinson posted a blog post

How to interpret and use more than just a standard tool-box

How to apply statistics to manage risks and verify/validate processes in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows:ISO standards and FDA/MDD regulations regarding the use of statistics.Basic vocabulary and concepts, including distributions such as binomial, hypergeometric, and Normal, and transformations into Normality.Statistical Process ControlStatistical methods for…See More
Jan 23
John Robinson posted events
Jan 21
John Robinson posted a blog post

eCTD Submissions of IND-NDA to the US FDA, EU and Canada

The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies.  Reformatting for multiple submissions is substantially limited.  The CTD has improved the regulatory review processes and enabled implementation of good review practices. The…See More
Jan 18
John Robinson posted a blog post

Effective Technical Writing in the Life Sciences

Technical writing and its role within the life sciences. Technical writers produce a variety of technical documents that are required to manage and direct regulated operations and to meet regulatory requirements. We will spend some time in this webinar discussing those document types, their importance, and the consequences of the messages are unclear or misunderstood.After setting the stage for this content, we delve into the writing process beginning with the audience and how the audience must…See More
Jan 9
John Robinson posted a blog post

How the FDA interprets advertising and promotion in principle and in fact

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe…See More
Jan 7
John Robinson posted a blog post

6-Hour Virtual Seminar on FDA's Software Monsters

The complexity and vulnerability of software is expanding exponentially, so fast that Congress removed some device software from FDA’s jurisdiction.  The remaining software regulated by FDA presents a degree of a risk to health that creates a public health concern.  Part of that risk involves the intentional activity that can conflict, intrude or destroy software.  The problems are taking center stage in the “healthcare software” dialogue.  What issues can compromise or defeat the functional…See More
Jan 2
John Robinson posted a blog post

Nutrition Facts labels of pure maple syrup and honey

FDA Commissioner, Scott Gottlieb, has announced a major overhaul of the FDA’s update to the Nutrition Facts label on products. This overhaul, the first in nearly twenty years, is aimed at empowering consumers by furnishing information on Nutrition Facts labels pure maple syrup and honey that ensures greater accuracy and is more science-based. With this, the FDA wants to help consumers make more informed and healthier choices.This update to the Nutrition Facts label has incorporated the latest…See More
Dec 14, 2018
John Robinson posted a blog post

What are the FDA's Process Validation requirements?

Process Validation (PV), according to the FDA, is collecting and assessing data right from the design stage till the production stage. PV is set out for all the stages of production for a product in the FDA-regulated industries. The core purpose of PV is to establish scientific proof that any process being employed has the capability of delivering quality products consistently.The FDA’s process validation requirements are set out in its general principles of Process Validation. Starting from…See More
Dec 10, 2018
John Robinson posted a blog post

Will smart devices be the smartphones of the medical device industry?

This is how the current-day situation of administering medical care runs: in the event of a medical need, the patient or someone attached to her is expected to sense the difficulty and call up the medical center to which the patient is attached. Help arrives after this is done. The medical practitioner may come over and attend to the patient at her location if the situation permits. Or else, the ambulance has to be called. All this has to done during what is called the Golden Hour: the most…See More
Nov 29, 2018
John Robinson posted events
Nov 29, 2018
John Robinson posted a blog post

A Process Approach to Quality Management Systems

ISO 13485:2016 describes a process approach to Quality Management Systems for Medical Devices.  This 6 -hour virtual seminar will help you to understand the process approach and develop an effective Quality Management System (QMS) for Medical Device Companies.  A well-structured QMS meets the requirements of the Quality System Regulations and is both effective and efficient.  The regulations require that manufacturers “establish and maintain a quality system that is appropriate for the specific…See More
Nov 26, 2018
John Robinson posted a blog post

FDA Scrutiny of Promotion and Advertising Practices

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe…See More
Nov 20, 2018
John Robinson posted a blog post

Applied Statistics for FDA Process Validation

 In Guidance for Industry Process Validation: General Principle and Practices, process validation is defined as, ""...the collection and evaluation of data, from the process design stage through commercial production.." The guidance further delineates the 'process design stage through commercial production' into three distinct stages of the product lifecycle:Stage 1: Process Design: The commercial manufacturing process is defined during this stage based on knowledge gained through development…See More
Nov 19, 2018
John Robinson posted events
Oct 25, 2018
John Robinson posted events
Sep 5, 2018

Profile Information

Area of Expertise or Interest?
GlobalCompliancePanel focuses primarily on providing extensive and quality training in these core areas and anything related to them:
Risk Management
Regulatory Compliances
Corporate Governance
Quality Management
Type of Affiliation?
Industry
Years of Experience in MedTech Field
10

John Robinson's Photos

  • Add Photos
  • View All

John Robinson's Blog

How to interpret and use more than just a standard tool-box

Posted on January 23, 2019 at 5:51am 0 Comments

How to apply statistics to manage risks and verify/validate processes in R&D, QA/QC, and Manufacturing, with examples derived mainly from the medical device design/manufacturing industry. The flow of topics over the 2 days is as follows:

  • ISO standards and FDA/MDD regulations regarding the use of statistics.
  • Basic vocabulary and concepts, including distributions such as binomial, hypergeometric, and Normal, and transformations into Normality.
  • Statistical…
Continue

eCTD Submissions of IND-NDA to the US FDA, EU and Canada

Posted on January 18, 2019 at 5:16am 0 Comments

The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies.  Reformatting for multiple submissions is substantially limited.  The CTD has improved the regulatory review processes and enabled implementation of good review…

Continue

Effective Technical Writing in the Life Sciences

Posted on January 9, 2019 at 6:44am 0 Comments

Technical writing and its role within the life sciences. Technical writers produce a variety of technical documents that are required to manage and direct regulated operations and to meet regulatory requirements. We will spend some time in this webinar discussing those document types, their importance, and the consequences of the messages are unclear or misunderstood.

After setting the stage for this content, we delve into the writing process beginning with the audience and how the…

Continue

How the FDA interprets advertising and promotion in principle and in fact

Posted on January 7, 2019 at 7:28am 0 Comments

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are…

Continue

Comment Wall (2 comments)

You need to be a member of MedTech I.Q. to add comments!

Join MedTech I.Q.

At 10:49am on October 31, 2014, FRANK KWABENA said…


Good Day,

How is everything with you, I picked interest on you after going through your short profile and deemed it necessary to write you immediately. I have something very vital to disclose to you, but I found it difficult to express myself here, since it's a public site.Could you please get back to me on:( mr.frankkwabena@yahoo.com.hk ) for the full details.

Have a nice day

Thanks God bless.

Mr Frank.

At 8:52am on August 20, 2014, David Hurley said…

Hello my good friend,

How are you? I have something very vital to disclose to you, but I found it difficult to express myself here, since it's a public site. contact me through my email: david.hurley27@yahoo.com

David Hurley.

 
 
 

© 2019   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service